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Assessing  the  severity  of  hypertension  entails  study  of  dam-
age to  target  organs,  including  the  retina.  Fundoscopy
is  an  important  test  for  this purpose,  providing  easy
direct  observation  in  vivo  of  the  retinal  microvasculature,
which anatomically  and physiologically  bears  close  similar-
ities  to cerebral,  coronary  and  renal  microvasculature.1,2
The  relationship  between  alterations  in the  retinal  vas-
culature,  assessed  qualitatively  by  fundoscopy  using  the
Keith-Wagener-Barker  or  Scheie  classification  systems,  and
current  or  previous  high  blood  pressure  (BP)  has  been  amply
demonstrated,  as  has  their  prognostic  value  for  cardio-
vascular  and  renal  morbidity  and  mortality,  especially  in
the  case  of  exudative  retinopathy.1,3 However,  the pre-
dictive  value  of  less  severe  alterations  such  as  arteriolar
narrowing,  widening  of  the  light  reflex  and  arteriovenous
nicking  is more  uncertain,  given  the subjective  nature  of
their  assessment.2,4 Recent  studies  using  semi-automated
computer-based  retinal  imaging  programs  applied  to  high-
definition  digital  photographs  and  laser  Doppler  flowmetry,
among  other  techniques,  have  provided  detailed  data,  not
DOI of original article: http://dx.doi.org/10.1016/j.repce.2017.06.014
 Please cite this article as: Nogueira JB. Repercussão microvascular retineana e hipertensão noturna -- alvos terapêuticos a não esquecer.
Rev Port Cardiol. 2018;37:175--177.
E-mail address: jnogueira@medicina.ulisboa.pt
only  qualitative  but,  importantly,  quantitative,  on  a range
of  parameters  of  the retinal  vasculature  including  arteri-
olar  wall-to-lumen  ratio,  caliber,  tortuosity,  vasomotricity,
and  branching  patterns  and  relative  diameters  of  arte-
rioles  and  venules.2,3,5 These,  in a more  robust  fashion
than  the subjective  assessments  of  older  methods,  have
established  or  confirmed  significant  associations  between
the  early  structural  and functional  alterations  of  the ini-
tial stages  of hypertension  and coronary  artery  disease,
heart  failure,  stroke,  cognitive  dysfunction,  microalbumin-
uria  and  renal  dysfunction,  left  ventricular  hypertrophy,
and  increased  carotid  intima-media  thickness  and  arte-
rial  stiffness.2,3 Some  studies  have  shown  the value  of
these  new  techniques  for  predicting  the development  or
worsening  of hypertension,2,3,6 and  genetic  studies  have
identified  loci  and polymorphisms  that  are associated  with
both  changes  in  arteriolar  caliber  and  regulation  or  elevation
of  BP.7,8
Interestingly,  some authors  have  described  an  associa-
tion  between  increased  venule  caliber  and  the  incidence
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of  hypertension  and  risk  of  stroke,  especially  lacunar
stroke.2,3,6
Ambulatory  blood  pressure  monitoring  (ABPM)  has  shown
the  significance  of  certain  abnormalities  in the 24-hour
circadian  profile  with  regard  to target  organ  damage  and
cerebral,  cardiovascular  and renal  morbidity  and mortal-
ity,  as  seen  in both  studies  of hypertensives  and  population
studies.1 Of  these  abnormalities,  non-dipping  and  noctur-
nal  hypertension  are most  often  independently  associated
with  increased  risk  of  target  organ  damage  and  worse
prognosis,  with  various  studies  having  shown  more  severe
cardiac,  cerebral,  renal  and  macrovascular  repercussions
in  these  patients.9--11 It  should  be  noted  that  there  have
been  few  studies  on  the  relationship  between  vascular
abnormalities  in hypertensive  retinopathy  and  circadian  pat-
terns  on  ABPM,  in particular  nocturnal  BP, and  some  are
contradictory.12--15
The  study  by Duarte  et  al.  published  in this  issue  of
the  Journal16 does  in fact analyze  precisely  this  relation-
ship  between  24-hour  and  nocturnal  BP  by ABPM  and  the
presence  and  severity  of  hypertensive  retinopathy,  assessed
qualitatively  by  fundoscopy  and graded  using  the Scheie
classification,  in a  group  of  46  hypertensives,  most of  them
medicated  but  only a  third controlled.
Despite  the limitations  pointed  out  by  the authors,  mainly
related  to  the  small  study  population,  the  study  clearly
showed  not only the high  prevalence  of  retinopathy  in these
hypertensives  but  also  the crucial  role  of nocturnal  BP,  espe-
cially  systolic,  in  the  presence  and  severity  of retinopathy.
There  were  also  associations  between  retinopathy  and  age
and  duration  of  hypertension,  as  described  elsewhere,2,3
particularly  when  the same  classification  system  was  used,
and  in  which  most  patients  were in the  sclerotic  stage of
retinopathy  (37  patients  in  the  present  study).  Regarding
the  mean  daytime  and nocturnal  BP levels  of  this  patient
group,  unusually,  mean  nocturnal  values  were  higher  than
daytime  levels,  which  raises the question  whether  they
included  a  large  number  of inverted  dippers  (which  was  not
the  case),  or  that  some  may  have  suffered  from  obstruc-
tive  sleep  apnea  or  other  sleep  disorders,  which  the authors
do  not  mention.  It  would  have  been  interesting  to  know
the  nocturnal  BP levels  of  dippers  and  non-dippers  in this
group,  since  nocturnal  BP  can  be  high  even  in dippers,17
which  may  be  why  there  were  no  differences  in the  pres-
ence  and severity  of retinopathy  between  dippers  and
non-dippers.
The  small  sample  size  is  probably  the  reason  that  no
association  was  found  between  the presence  of  retinopa-
thy  and  cardiac  involvement,  as  has  been described  in
other  studies.3 Similarly,  medicated  and  controlled  patients
were  no  different  in terms  of  the  presence  of  retinopathy,
although  improvements  in  structural  alterations  of  the reti-
nal  vasculature  have  been  reported  following  BP control,3,18
particularly  with  drugs  that  act  on  the  renin-angiotensin-
aldosterone  system  and  with  calcium  channel  blockers,
which  were  used  in this  study. Such improvements  have
been  amply  demonstrated,  especially  in cases  of exudative
retinopathy  (which  only one patient  presented  in the  study
by  Duarte  et al.)  and  when  the assessment  of retinopathy  is
quantitative  as  well  as  qualitative,  using sophisticated  and
precise  computer  algorithms,  which  was  not the  case  in the
present  study.  The  apparent  lack  of  improvement  seen  in
this  study  may  thus be because  BP  control  had  not been
achieved  for  sufficient  time  to  take  effect,  or  due  to  the
methods  used  to  assess  retinopathy,  or  to  the patients’  age
and  duration  of  hypertension,  leading  to  a  larger  proportion
of  sclerotic  lesions  that  are  less  likely  to  regress.  If patient
numbers  had  permitted  such  an analysis,  it  would  have  been
interesting  to  assess  whether  there  were  significant  differ-
ences  in retinal  findings  or  in nocturnal  BP levels  between
non-medicated  and medicated  but  not  controlled  subjects.
Furthermore,  the  study  does  not  report  office  BP mea-
surements,  and  thus cannot  clarify  whether  some  patients
had  masked  hypertension  and  if so,  whether  retinopathy  in
this  group  was  similar  to  that  of  the other  hypertensives,
as  has  been  reported  for  other  organ  damage,9 or  how  it
related  to nocturnal  BP.
In  conclusion,  despite  the  limitations  pointed  out  above
with  regard  to  population  size  and  the methodology  for
assessing  the fundoscopy  findings,  the present  study  has
the merit  of  demonstrating  the importance  of  nocturnal
BP  in alterations  in the retinal  vasculature,  and of  call-
ing  attention  to  these  alterations,  which are frequently
underestimated  and are  potential  therapeutic  targets.  They
may  also  play  an  important  role  in early  assessment  of  the
severity  of  hypertension,  particularly  with  regard  to  car-
diovascular  and  renal  risk,  as  well  as  in monitoring  the
efficacy  of  and  adherence  to  antihypertensive  medication;
when  such  lesions  are  detected  but  the  patient  has  appar-
ently  normal  BP  levels,  they  may  reflect  inadequate  control
of  nocturnal  BP.
Further  studies  are  awaited,  with  larger  samples
and  more  detailed  assessment  of  the retinal  vascular
architecture,19 that  could  widen our  understanding  of
hypertensive  microvascular  alterations,  both  arteriolar  and
venular,  and  their  relationship  with  changes  in  circadian
BP  profiles,  therapeutic  efficacy,  the possible  benefits  of
chronotherapy,  and --  for  example  in cases  of  white-coat
hypertension  --  the  decision  whether  to  initiate  antihyper-
tensive  therapy.
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